Chemoprevention of colorectal cancerGWYN, Karin; SINICROPE, Frank A.The American journal of gastroenterology. 2002, Vol 97, Num 1, pp 13-21, issn 0002-9270, 9 p.Article

Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic ImplicationsSINICROPE, Frank A; SARGENT, Daniel J.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1506-1512, issn 1078-0432, 7 p.Article

Colorectal cancer prevention : Is an ounce of prevention worth a pound of cure?GILL, Sharlene; SINICROPE, Frank A.Seminars in oncology. 2005, Vol 32, Num 1, pp 24-34, issn 0093-7754, 11 p.Article

Aspirin and Colorectal Cancer: Back to the FutureTOUGERON, David; SHA, Dan; MANTHRAVADI, Sashidhar et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1087-1094, issn 1078-0432, 8 p.Article

Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cellsSINICROPE, Frank A; PENINGTON, Robert C; XI MING TANG et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8284-8292, issn 1078-0432, 9 p.Article

Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cellsYUNJIE SUN; XI MING TANG; HALF, Elizabeth et al.Cancer research (Baltimore). 2002, Vol 62, Num 21, pp 6323-6328, issn 0008-5472, 6 p.Article

Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trialSAMPLE, Dory A; SINICROPE, Pamela S; WARGOVICH, Michael J et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 3, pp 281-285, issn 1055-9965Article

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situHALF, Elizabeth; XI MING TANG; GWYN, Karin et al.Cancer research (Baltimore). 2002, Vol 62, Num 6, pp 1676-1681, issn 0008-5472Article

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy TrialsSINICROPE, Frank A; FOSTER, Nathan R; YOON, Harry H et al.Journal of clinical oncology. 2012, Vol 30, Num 4, pp 406-412, issn 0732-183X, 7 p.Article

Thymidylate synthase expression in colon carcinomas with microsatellite instabilitySINICROPE, Frank A; REGO, Rafaela L; WITZIG, Thomas E et al.Clinical cancer research. 2006, Vol 12, Num 9, pp 2738-2744, issn 1078-0432, 7 p.Article

HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumorsHALF, Elizabeth; BROADDUS, Russell; DANENRERG, Kathleen D et al.International journal of cancer. 2004, Vol 108, Num 4, pp 540-548, issn 0020-7136, 9 p.Article

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)YOON, Harry H; TOUGERON, David; SINICROPE, Frank A et al.Clinical cancer research (Print). 2014, Vol 20, Num 11, pp 3033-3043, issn 1078-0432, 11 p.Article

Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant ChemotherapySINICROPE, Frank A; FOSTER, Nathan R; YOTHERS, Greg et al.Cancer. 2013, Vol 119, Num 8, pp 1528-1536, issn 0008-543X, 9 p.Article

Prognostic Impact of Body Mass Index Stratified by Smoking Status in Patients With Esophageal AdenocarcinomaYOON, Harry H; LEWIS, Mark A; QIAN SHI et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4561-4567, issn 0732-183X, 7 p.Article

Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancersSINICROPE, Frank A; REGO, Rafaela L; FOSTER, Nathan et al.The American journal of gastroenterology. 2006, Vol 101, Num 12, pp 2818-2825, issn 0002-9270, 8 p.Article

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147GONSALVES, Wilson I; MAHONEY, Michelle R; HUBBARD, Joleen M et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju106.1-dju106.8Article

DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon CancerTreatment (NCCTG NO147)LEE, Adam M; QIAN SHI; PAVEY, Emily et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 12, issn 0027-8874, 296.1-296.12Article

A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma CellsSMOOT, Rory L; BLECHACZ, Boris R. A; WERNEBURG, Nathan W et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 5, pp 1960-1969, issn 0008-5472, 10 p.Article

Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instabilitySINICROPE, Frank A; REGO, Rafaela L; GARRITY-PARK, Megan M et al.International journal of cancer. 2007, Vol 120, Num 6, pp 1232-1238, issn 0020-7136, 7 p.Article